Clinical Trials Browser

Neoplasms, Endometrial Neoplasms

Locally Advanced Cervical Cancer

Endometrial Neoplasms

Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms

Adenocarcinoma, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Locally Advanced Cervical Adenocarcinoma

Ovarian Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms

Endometrial Neoplasms

Neoplasm Metastasis, Uterine Neoplasms, Endometrial Neoplasms

Ovarian Neoplasms

Locally Advanced Cervical Carcinoma

Ovarian Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Neoplasms, Endometrial Neoplasms

Recurrence, Endometrial Neoplasms

Ovarian Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Endometrial Neoplasms

Endometrial Neoplasms

Ovarian Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Advanced Cervical Cancer

Uterine Cervical Neoplasms

Low Grade Serous Ovarian Cancer

Head and Neck Neoplasms, Pelvic Neoplasms

Ovarian Neoplasms

Frailty, Ovarian Neoplasms, Endometrial Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaccinia

Fallopian Tube Neoplasms, Ovarian Neoplasms

Pelvic Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Neoplasms, Endometrial Neoplasms

Uterine Neoplasms, Endometrial Neoplasms

Endometrial Neoplasms

Carcinoma, Ovarian Epithelial

Ovarian Neoplasms

Ovarian Neoplasms

Endometrial Clear Cell Adenocarcinoma

Ovarian Neoplasms

Digestive System Diseases, Ovarian Neoplasms

Ovarian Neoplasms

Fallopian Tube Neoplasms, Peritoneal Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Breast Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

Clinical Trials

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

eVOLVECervical

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

FRAmework-01

PAROLA

DO-01

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

MAESTRA 2

TroFuse-033

TroFuse-036

TroFuse-021

A Study of Intra-operative Imaging in Women With Ovarian Cancer

Fern-EC-01

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

ASPENOVA

A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy Followed by CCRT

A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian Cancer

TroFuse-022

DE-01

RAINFOL-03

RAINFOL-04

OVATION-3

XPORT-EC-042

Vaginal Cuff Brachytherapy Fractionation Study

A Study of SHR-A1811 in Subjects With Ovarian Cancer

A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01)

HOTT

A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

RAMP 301

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

PHOCUS

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

BEFORE

FOCUS / KOV-04

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

ENDO-3

RAINBO-RED

TREVI-OC-01

SENTOV II

HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer

SAVE

SALVOVAR

ESTANVO

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

MATAO

Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer

MOVES